Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (11): 1194-1197.DOI: 10.3969/j.issn.1673-8640.2021.11.022
Previous Articles Next Articles
Online:2021-11-30
Published:2021-12-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.11.022
| [1] |
ZHANG J, DING L, HOLMFELDT L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia[J]. Nature, 2012, 481(7380):157-163.
DOI URL |
| [2] | 刘艳荣. 实用流式细胞术——血液病篇[M]. 北京: 北京大学医学出版社, 2010. |
| [3] | 中国抗癌协会血液肿瘤专业委员会, 中华医学会血液学分会白血病淋巴瘤学组. 中国成人急性淋巴细胞白血病诊断与治疗指南(2016年版)[J]. 中华血液学杂志, 2016, 37(10):837-845. |
| [4] | 郜慧芳, 郑胡镛. 混合表型急性白血病诊断标准研究进展[J]. 中华儿科杂志, 2012, 50(5):368-370. |
| [5] |
ARBER D A, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20):2391-2405.
DOI URL |
| [6] |
CHOPRA A, BAKHSHI S, PRAMANIK S K, et al. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL[J]. Eur J Haematol, 2014, 92(3):211-218.
DOI URL |
| [7] |
BOND J, GRAUX C, LHERMITTE L, et al. Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia:a group for research on adult acute lymphoblastic leukemia study[J]. J Clin Oncol, 2017, 35(23):2683-2691.
DOI URL |
| [8] | 廖红艳, 孙卓怡, 王彦兮, 等. 青少年和成人急性T淋巴细胞白血病/淋巴瘤126例临床分析及急性早期前体T淋巴细胞白血病/淋巴瘤分型预后意义的初步探讨[J]. 中华血液学杂志, 2019, 40(7):561-567. |
| [9] | 国家卫生健康委办公厅. 儿童急性淋巴细胞白血病诊疗规范(2018年版)[EB/OL]. (2018-10-16) [2018-10-08]. http://www.nhc.gov.cn/yzygj/s7653/201810/aef82930c1af4fc5bf325938e2fcb075.shtml. |
| [10] | 刘雅宁, 孟予城, 杨淑莲, 等. 急性早期前体T淋巴细胞白血病伴CD15、CD58、CD123阳性表达1例报道[J]. 检验医学, 2018, 33(9):868-871. |
| [11] | 弓晓媛, 王迎, 刘兵城, 等. 成人早期前体T细胞急性淋巴细胞白血病的临床特征和预后分析[J]. 中华血液学杂志, 2018, 39(12):977-982. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
